Agilent Technologies to acquire Biocare Medical for $950M

Agilent Technologies Inc. has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million.

“The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth through customer-centric innovation and disciplined capital allocation.”investor.agilent.com

• 2 sources
• investor.agilent.comAgilent Technologies, Inc. - Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology SolutionsMar 9, 2026
• barchart.comAgilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology SolutionsAgilent Technologies Inc.Mar 9, 2026

Summarized from public sources; check the original articles before acting on it.